Search results for "tumor response rate"

Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases

Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases

When hepatocellular carcinoma spreads to the lymph nodes, it is classified as advanced liver cancer, typically requiring systemic treatment such as...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its Hematology Hospital won eight of the...
Pediatric Crohn’s: Switching Biologics Yields Similar Remission Rates Despite Lower Blood Drug Levels

Pediatric Crohn’s: Switching Biologics Yields Similar Remission Rates Despite Lower Blood Drug Levels

Pediatric and adolescent Crohn’s disease patients who switch to infliximab after losing responsiveness to adalimumab...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
Found an Ovarian Cyst? Endometriosis Doesn't Always Require Surgery

Found an Ovarian Cyst? Endometriosis Doesn't Always Require Surgery

Every period came with severe abdominal pain. She managed with painkillers, telling herself she was simply someone with...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver...